The effects of BRCA1,ERCC1,β-tubulinⅢ,RRM1 on the determination of chemotherapy drugs and postoperative survival trend in patients with non-small cell lung cancer atⅡ～Ⅳstage

doi:10.3969/j.issn.1002-7386.2019.01.001

Home>Articles>The effects of BRCA1,ERCC1,β-tubulinⅢ,RRM1 on the determination of chemotherapy drugs and postoperative survival trend in patients with non-small cell lung cancer atⅡ～Ⅳstage

DOI: 10.3969/j.issn.1002-7386.2019.01.001

The effects of BRCA1,ERCC1,β-tubulinⅢ,RRM1 on the determination of chemotherapy drugs and postoperative survival trend in patients with non-small cell lung cancer atⅡ～Ⅳstage

Machine-generated Keywords：

Publication Date：2019-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：6( 5-9,14 )

Hebei Medical Journal

ISTIC

ISSN：1002-7386

Year, Vol.(Issue)：2019,41(1)